TCT17 Presentation Slides | PARTNER 2A and SAPIEN 3 Cost-Effectiveness
Description:
TCT17 Presentation Slides | PARTNER 2A and SAPIEN 3 Cost-Effectiveness: TAVR vs. SAVR in Intermediate-Risk Patients With Aortic Stenosis
Date: October 31, 2017
Keywords: Transcatheter Cardiovascular Therapeutics, TCT17 Slides, Transcatheter Aortic Valve Replacement, Cost-Benefit Analysis, Heart Valve Prosthesis Implantation, Aortic Valve Stenosis